WHO ICTRP trial
An exploratory study of targeted activation of CIK cells and PD-1 mab in…
ChiCTR2200059813 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200059813 |
|---|---|
| Public title | An exploratory study of targeted activation of CIK cells and PD-1 mab in sequential therapy of advanced liver cancer |
| Scientific title | An exploratory study of targeted activation of CIK cells and PD-1 mab in sequential therapy of advanced liver cancer |
| Primary sponsor | Beijing GoBroad Boren Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Advanced primary liver cancer |
| Interventions | Experimental group:Sequential therapy with targeted activation of CIK cells and PD-1 mab |
| Registration date | May 12, 2022 |
| Target size | Experimental group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: